Jump to navigation
INAPPROPRIATE further investigation after normal colonoscopy could have cost as much as $25 million in the first few years of the National Bowel Cancer Screening Program (NBCSP), research suggests.
To continue reading please login or sign up for access.
Niamh Mullen is a medical writer and former news director of MO.
More articles by this author >
Cirrus Media is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.